Jubilant existence Sciences stocks surged 6 according to cent on Monday, following the Noida-based totally pharma company‘s assertion about US regulator’s approval for Levetiracetam injection, used in thetreatment of epilepsy.
approval for the Levetiracetam injection will generate incremental sales for the corporation, analystsstated.
With this approval, Jubilant lifestyles Sciences’ general Abbreviated New Drug application (ANDA) approvals rose to 517 in numerous areas globally, the business enterprise stated.
Jubilant lifestyles Sciences shares closed 4.29 in keeping with cent better at Rs. 368.1 apiece as compared to zero.24 consistent with cent fall inside the broader Sensex.
story first published on: June 06, 2016 10:11 (IST)
Tags: Jubilant existence Sciences, Jubilant existence Sciences stocks, Levetiracetam Injection, Keppra injection
through Taboola subsidized hyperlinks FROM THE web